Nonetheless, the use of COX-2 inhibitor and other NSAIDs (non-steroidal anti-inflammatory drugs) for cancer therapy remains questionable because of the associated side effects of the NSAIDs, varying from moderate gastrointestinal toxicity to cardiotoxicity [6]. The gene discussed is PTGS2; the disease is cancer.